Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

More On ALPMF

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Astellas Pharma, Inc. (ALPMF)

-Other OTC
10.60 0.00(0.00%) 01:10
Add to Portfolio
Prev Close:10.60
Open:10.60
Bid:N/A
Ask:N/A
1y Target Est:50.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:10.49 - 63.15
Volume:0
Avg Vol (3m):1,468
Market Cap:23.77b
P/E (ttm):23.66
EPS (ttm):0.45
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ALPMF at this time.

Key Statistics

Forward P/E (1 yr):18.28
P/S (ttm):1.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Mar-14) :0.46
Quarterly EPS Est (Mar-14) :0.08
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Astellas Pharma Inc. manufactures, markets, and imports/exports pharmaceutical products worldwide. The company focuses on therapeutic areas of urology, immunology and infectious diseases, oncology, neuroscience, and diabetes mellitus complications... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback